Literature DB >> 1660144

CD10/neutral endopeptidase 24.11 hydrolyzes bombesin-like peptides and regulates the growth of small cell carcinomas of the lung.

M A Shipp1, G E Tarr, C Y Chen, S N Switzer, L B Hersh, H Stein, M E Sunday, E L Reinherz.   

Abstract

Bombesin-like peptides are essential autocrine growth factors for many small cell carcinomas (SCCas) of the lung. Herein, we demonstrate that these malignant pulmonary neuroendocrine cells express low levels of the cell surface metalloendopeptidase CD10/neutral endopeptidase 24.11 (CD10/NEP, common acute lymphoblastic leukemia antigen) and that this enzyme hydrolyzes bombesin-like peptides. The growth of bombesin-like peptide-dependent SCC as is inhibited by CD10/NEP and potentiated by CD10/NEP inhibition. The results provide evidence that CD10/NEP is involved in the regulation of tumor cell proliferation. Since SCCa of the lung occurs almost exclusively in cigarette smokers and cigarette smoke inactivates CD10/NEP, decreased cell surface CD10/NEP enzymatic activity may be causally related to the development of SCCa of the lung.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1660144      PMCID: PMC52990          DOI: 10.1073/pnas.88.23.10662

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Oat-cell carcinoma of the lung. Its origin and relationship to bronchial carcinoid.

Authors:  K G Bensch; B Corrin; R Pariente; H Spencer
Journal:  Cancer       Date:  1968-12       Impact factor: 6.860

2.  Increased pulmonary neuroendocrine cells with bombesin-like immunoreactivity in adult patients with eosinophilic granuloma.

Authors:  S M Aguayo; T E King; J A Waldron; K M Sherritt; M A Kane; Y E Miller
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

3.  Peptidase modulation of the pulmonary effects of tachykinins in tracheal superfused guinea pig lungs.

Authors:  M A Martins; S A Shore; N P Gerard; C Gerard; J M Drazen
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

4.  Bombesin stimulation of DNA synthesis and cell division in cultures of Swiss 3T3 cells.

Authors:  E Rozengurt; J Sinnett-Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

5.  Statistical analysis of enzyme kinetic data.

Authors:  W W Cleland
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

6.  Catabolism of gastrin releasing peptide and substance P by gastric membrane-bound peptidases.

Authors:  N W Bunnett; R Kobayashi; M S Orloff; J R Reeve; A J Turner; J H Walsh
Journal:  Peptides       Date:  1985 Mar-Apr       Impact factor: 3.750

7.  Bombesin and the C-terminal tetradecapeptide of gastrin-releasing peptide are growth factors for normal human bronchial epithelial cells.

Authors:  J C Willey; J F Lechner; C C Harris
Journal:  Exp Cell Res       Date:  1984-07       Impact factor: 3.905

8.  A substance P antagonist inhibits vagally induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea pig.

Authors:  J M Lundberg; A Saria; E Brodin; S Rosell; K Folkers
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

Review 9.  Selective expression of the common acute lymphoblastic leukemia (gp 100) antigen on immature lymphoid cells and their malignant counterparts.

Authors:  M F Greaves; G Hariri; R A Newman; D R Sutherland; M A Ritter; J Ritz
Journal:  Blood       Date:  1983-04       Impact factor: 22.113

10.  Distribution of common acute lymphoblastic leukemia antigen in nonhematopoietic tissues.

Authors:  R S Metzgar; M J Borowitz; N H Jones; B L Dowell
Journal:  J Exp Med       Date:  1981-10-01       Impact factor: 14.307

View more
  51 in total

1.  Activity-based probes for the proteomic profiling of metalloproteases.

Authors:  Alan Saghatelian; Nadim Jessani; Arul Joseph; Mark Humphrey; Benjamin F Cravatt
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-25       Impact factor: 11.205

Review 2.  Regulatory mechanisms that modulate signalling by G-protein-coupled receptors.

Authors:  S K Böhm; E F Grady; N W Bunnett
Journal:  Biochem J       Date:  1997-02-15       Impact factor: 3.857

3.  LC/MS evaluation of metabolism and membrane transport of bombesin peptides.

Authors:  Dongyu Gu; Ying Ma; Gang Niu; Yongjun Yan; Lixin Lang; Haji Akber Aisa; Haji Akber Aisaand; Haokao Gao; Dale O Kiesewetter; Xiaoyuan Chen
Journal:  Amino Acids       Date:  2010-07-30       Impact factor: 3.520

4.  Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling.

Authors:  M Sumitomo; R Shen; M Walburg; J Dai; Y Geng; D Navarro; G Boileau; C N Papandreou; F G Giancotti; B Knudsen; D M Nanus
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

Review 5.  Long-term neprilysin inhibition - implications for ARNIs.

Authors:  Duncan J Campbell
Journal:  Nat Rev Cardiol       Date:  2016-12-15       Impact factor: 32.419

6.  Role of neprilysin in airway inflammation induced by diesel exhaust emissions.

Authors:  Simon S Wong; Nina N Sun; Cynthia D Fastje; Mark L Witten; R Clark Lantz; Bao Lu; Duane L Sherrill; Craig J Gerard; Jefferey L Burgess
Journal:  Res Rep Health Eff Inst       Date:  2011-06

7.  Soluble recombinant neutral endopeptidase (CD10) as a potential antiinflammatory agent.

Authors:  N J Solan; P E Ward; S P Sanders; M C Towns; J M Bathon
Journal:  Inflammation       Date:  1998-02       Impact factor: 4.092

8.  CD10/NEP in non-small cell lung carcinomas. Relationship to cellular proliferation.

Authors:  R K Ganju; M Sunday; D G Tsarwhas; A Card; M A Shipp
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

9.  CD10/neutral endopeptidase 24.11 regulates fetal lung growth and maturation in utero by potentiating endogenous bombesin-like peptides.

Authors:  K A King; J Hua; J S Torday; J M Drazen; S A Graham; M A Shipp; M E Sunday
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

10.  Neurotensin is an autocrine trophic factor stimulated by androgen withdrawal in human prostate cancer.

Authors:  I Sehgal; S Powers; B Huntley; G Powis; M Pittelkow; N J Maihle
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.